Cargando…

Erythropoietin monotherapy for neuroprotection after neonatal encephalopathy in low-to-middle income countries: a systematic review and meta-analysis

OBJECTIVE: We examined whether erythropoietin monotherapy improves neurodevelopmental outcomes in near-term and term infants with neonatal encephalopathy (NE) in low-middle income countries (LMICs). METHODS: We searched Pubmed, Embase, and Web of Science databases to identify studies that used eryth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivain, Phoebe, Montaldo, Paolo, Khan, Aamir, Elagovan, Ramyia, Burgod, Constance, Morales, Maria Moreno, Pant, Stuti, Thayyil, Sudhin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440196/ https://www.ncbi.nlm.nih.gov/pubmed/34175900 http://dx.doi.org/10.1038/s41372-021-01132-4

Ejemplares similares

Effect of intra-partum Oxytocin on neonatal encephalopathy: a systematic review and meta-analysis
por: Burgod, Constance, et al.
Publicado: (2021)

Association of Total Sarnat Score with brain injury and neurodevelopmental outcomes after neonatal encephalopathy
por: Morales, Maria Moreno, et al.
Publicado: (2021)

White matter injury after neonatal encephalopathy is associated with thalamic metabolite perturbations
por: Montaldo, Paolo, et al.
Publicado: (2020)

Informed consent rates for neonatal randomized controlled trials in low- and lower middle-income versus high-income countries: A systematic review
por: Patterson, Jacquelyn K., et al.
Publicado: (2021)

Therapeutic Hypothermia for Neonatal Encephalopathy in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
por: Pauliah, Shreela S., et al.
Publicado: (2013)

Whole-Body Hypothermia, Cerebral Magnetic Resonance Biomarkers, and Outcomes in Neonates With Moderate or Severe Hypoxic-Ischemic Encephalopathy Born at Tertiary Care Centers vs Other Facilities: A Nested Study Within a Randomized Clinical Trial
por: Thayyil, Sudhin, et al.
Publicado: (2023)

Hippocampus and hypothermia: A missing link
por: Montaldo, Paolo, et al.
Publicado: (2022)

Hypothermia for encephalopathy in low and middle-income countries (HELIX): study protocol for a randomised controlled trial
por: Thayyil, Sudhin, et al.
Publicado: (2017)

Need for more evidence in the prevention and management of perinatal asphyxia and neonatal encephalopathy in low and middle-income countries: A call for action
por: Krishnan, Vaisakh, et al.
Publicado: (2021)

Hypothermia for encephalopathy in low-income and middle-income countries: feasibility of whole-body cooling using a low-cost servo-controlled device
por: Oliveira, Vânia, et al.
Publicado: (2018)

Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh
por: Thayyil, Sudhin, et al.
Publicado: (2021)

Transcriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathy
por: Montaldo, Paolo, et al.
Publicado: (2020)

Neonatal Seizures—Perspective in Low-and Middle-Income Countries
por: Vegda, Hemadri, et al.
Publicado: (2022)

Parental and professional perceptions of informed consent and participation in a time-critical neonatal trial: a mixed-methods study in India, Sri Lanka and Bangladesh
por: Pant, Stuti, et al.
Publicado: (2021)

Magnetic Resonance Biomarkers in Neonatal Encephalopathy (MARBLE): a prospective multicountry study
por: Lally, Peter J, et al.
Publicado: (2015)

Therapeutic hypothermia initiated within 6 hours of birth is associated with reduced brain injury on MR biomarkers in mild hypoxic-ischaemic encephalopathy: a non-randomised cohort study
por: Montaldo, Paolo, et al.
Publicado: (2019)

Early Postnatal Heart Rate Variability in Healthy Newborn Infants
por: Oliveira, Vânia, et al.
Publicado: (2019)

Prospective Research in Infants with Mild Encephalopathy (PRIME) Identified in the First Six Hours of Life: Neurodevelopmental Outcomes at 18-22 Months
por: Chalak, Lina F, et al.
Publicado: (2018)

Erythropoietin: a multimodal neuroprotective agent
por: Byts, Nadiya, et al.
Publicado: (2009)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017)

Evaluating Neuroprotective Effects of Uridine, Erythropoietin, and Therapeutic Hypothermia in a Ferret Model of Inflammation-Sensitized Hypoxic-Ischemic Encephalopathy
por: Corry, Kylie A., et al.
Publicado: (2021)

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
por: Asadi, Bahador, et al.
Publicado: (2013)

Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy
por: Choi, Joo-Wan, et al.
Publicado: (2022)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
por: Chen, Jianmin, et al.
Publicado: (2016)

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
por: de Carvalho, Litia Alves, et al.
Publicado: (2018)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
por: Juenemann, Martin, et al.
Publicado: (2020)

The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)

Tackling racism in UK health research
por: Powell, Richard Antony, et al.
Publicado: (2022)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”
por: Chen, Jianmin, et al.
Publicado: (2016)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
por: Cho, Bongki, et al.
Publicado: (2021)

Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research
por: Oorschot, Dorothy E., et al.
Publicado: (2020)

Gemcitabine Monotherapy Associated with Posterior Reversible Encephalopathy Syndrome
por: Marrone, Luiz Carlos Porcello, et al.
Publicado: (2011)

Diagnostic accuracy of post-mortem cardiovascular magnetic resonance imaging in fetuses, newborns, and children
por: Thayyil, Sudhin, et al.
Publicado: (2012)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
por: Moransard, M., et al.
Publicado: (2017)

NAC and Vitamin D Improve CNS and Plasma Oxidative Stress in Neonatal HIE and Are Associated with Favorable Long-Term Outcomes
por: Jenkins, Dorothea D, et al.
Publicado: (2021)

Erythropoietin may improve the Outcome in Infants with Moderate to Severe Hypoxic Ischemic Encephalopathy
por: Al-Salam, Zakariya
Publicado: (2013)

Adapting AVATAR Therapy: Using Available Digital Technology for People Living with Auditory Verbal Hallucinations in Low- and Middle-Income Countries
por: Kapadia, Stuti Viren
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7qvobt7e97l9etgmd349ggs73